Complement activation causes energy and metabolism changes in endothelial cells.
补体激活导致内皮细胞能量和代谢发生变化。
基本信息
- 批准号:RGPIN-2019-06477
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2019
- 资助国家:加拿大
- 起止时间:2019-01-01 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
***The immune system is a network of proteins, cells, tissues, and organs*that protect the body against invaders (e.g., viruses, bacteria). Part of the*system's first line of defense is the complement system, which helps clear*invaders and damaged cells out of the body. When the clearance of such*invaders/damaged cells is needed, the complement cascade is activated,*resulting in the tagging of damaged cells rendering them target of clean up via*white blood cells, or in the formation of pores in the surface of invading*cells, causing their destruction. The inner lining of blood vessels the*endothelial cells is in constant contact with the complement system, but it*has regulators on its surface to prevent the spontaneous activation of*complement when and where it is not needed. Though normally tightly regulated, genetic*defects or the presence of inhibiting autoantibodies can impair complement*control, and spontaneous activation can happen, which can attack the normal,*unaffected endothelial cells. The mechanisms these cells engage to allow for*evasion of complement attack thus allowing for survival are currently only poorly*understood.******Our group has previously established a protocol allowing for complement*activation on endothelial cells. In this model, endothelial cells lose their*ability to migrate and are depleted of their energy stores (mainly*mitochondria, the powerhouse of the cell), but they do not die even after a*long exposure (6h). We here propose to determine the survival mechanisms being*engaged in endothelial cells during complement attack, as well as to determine*the metabolic/energetic changes occurring in these cells ultimately allowing them*to evade complement attack and survive. Consequently, we also aim to determine*the “tipping point” of these defense mechanisms, i.e. the factors that might*ultimately tip the cell's machinery to no longer withstand complement attack*and commit to clearance of these damaged cells that would otherwise harm the*organism.******We anticipate to find various ways*endothelial cells try to hold a balanced and functional intracellular state*while they are under complement attack, including inhibiting the machinery the*cells use to kill highly damaged cells, depending more on alternative sources*of energy (other than mitochondria), and trying to remove the pore from their*surfaces. Also, once we have determined the players in these mechanisms, we can*inhibit their activity used during survival state, when we expect to see the*cells commit to dying faster than if these mechanisms were active.******As the complement system is ubiquitously present throughout the body, we expect that results generated in the here proposed research*project will have the potential to generate fundamental new insights into*cell/tissue survival mechanisms of virtually all tissue/organ systems of the*body, not only the endothelial cells.*********
***免疫系统是一个由蛋白质、细胞、组织和器官组成的网络*,保护身体免受入侵者(例如病毒、细菌)的侵害。该系统第一道防线的一部分是补体系统,它有助于清除体内的入侵者和受损细胞。当需要清除此类*入侵者/受损细胞时,补体级联被激活,*导致受损细胞被标记,使它们成为通过*白细胞清除的目标,或者在入侵*细胞表面形成孔,导致其被破坏。血管内皮细胞与补体系统持续接触,但其表面有调节器,以防止补体在不需要的时间和地点自发激活。尽管通常受到严格调控,但遗传*缺陷或抑制性自身抗体的存在会损害补体*控制,并且可能发生自发激活,从而攻击正常的、*未受影响的内皮细胞。目前,人们对这些细胞逃避补体攻击从而得以生存的机制知之甚少。******我们的小组之前已经建立了一种允许补体*激活内皮细胞的方案。在此模型中,内皮细胞失去*迁移能力并耗尽其能量储存(主要*线粒体,细胞的动力源),但即使在长时间暴露(6小时)后它们也不会死亡。我们在这里建议确定补体攻击期间*参与内皮细胞的生存机制,以及确定*这些细胞中发生的代谢/能量变化,最终允许它们*逃避补体攻击并生存。因此,我们还旨在确定*这些防御机制的“临界点”,即可能*最终使细胞机制不再承受补体攻击*并致力于清除这些可能损害*生物体的受损细胞的因素。******我们期望找到各种方法*内皮细胞在受到补体攻击时尝试保持平衡和功能性的细胞内状态*,包括抑制*细胞的机制 用于杀死高度受损的细胞,更多地依赖替代能源(线粒体除外),并试图从其表面去除毛孔。此外,一旦我们确定了这些机制中的参与者,我们就可以*抑制它们在生存状态下使用的活动,当我们期望看到*细胞比这些机制活跃时更快地死亡时。******由于补体系统普遍存在于全身,我们预计这里提出的研究*项目中产生的结果将有可能对几乎所有组织/器官的*细胞/组织生存机制产生基本的新见解 *身体的系统,不仅仅是内皮细胞。*********
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Licht, Christoph其他文献
Severe atypical HUS caused by CFH S1191L-case presentation and review of treatment options
- DOI:
10.1007/s00467-009-1306-7 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:3
- 作者:
De, Sudarsana;Waters, Aoife M.;Licht, Christoph - 通讯作者:
Licht, Christoph
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.
- DOI:
10.1007/s00467-012-2138-4 - 发表时间:
2013-01 - 期刊:
- 影响因子:3
- 作者:
Kashtan, Clifford E.;Ding, Jie;Gregory, Martin;Gross, Oliver;Heidet, Laurence;Knebelmann, Bertrand;Rheault, Michelle;Licht, Christoph - 通讯作者:
Licht, Christoph
The Impact of Hypoparathyroidism Treatment on the Kidney in Children: Long-Term Retrospective Follow-Up Study
- DOI:
10.1210/jc.2015-2257 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:5.8
- 作者:
Levy, Isaac;Licht, Christoph;Harrington, Jennifer - 通讯作者:
Harrington, Jennifer
Platelet-associated complement factor H in healthy persons and patients with atypical HUS
- DOI:
10.1182/blood-2009-03-205096 - 发表时间:
2009-11-12 - 期刊:
- 影响因子:20.3
- 作者:
Licht, Christoph;Pluthero, Fred G.;Kahr, Walter H. A. - 通讯作者:
Kahr, Walter H. A.
Atypical Hemolytic-Uremic Syndrome: Genetic Basis, Clinical Manifestations, and a Multidisciplinary Approach to Management.
- DOI:
10.2147/jmdh.s245620 - 发表时间:
2023 - 期刊:
- 影响因子:3.3
- 作者:
Yerigeri, Keval;Kadatane, Saurav;Mongan, Kai;Boyer, Olivia;Burke, Linda L. G.;Sethi, Sidharth Kumar;Licht, Christoph;Raina, Rupesh - 通讯作者:
Raina, Rupesh
Licht, Christoph的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
- 批准号:82371223
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
- 批准号:82371103
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
- 批准号:82371799
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
- 批准号:82371145
- 批准年份:2023
- 资助金额:46.00 万元
- 项目类别:面上项目
基于CRISPR Activation转录激活系统的籼稻新型再生因子的挖掘
- 批准号:32301275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
- 批准号:82372202
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
cGAS-STING通路调控单核细胞活化参与Graves病发病的机制研究
- 批准号:82370787
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TXNIP调控实验性青光眼视乳头星形胶质细胞的激活及其机制研究
- 批准号:82371048
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
SOD1介导星形胶质细胞活化调控hNSC移植细胞存活的机制研究
- 批准号:82372136
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
- 批准号:82371152
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Infusion device optimization by addressing root causes of the inflammatory response
通过解决炎症反应的根本原因来优化输注装置
- 批准号:
10443241 - 财政年份:2022
- 资助金额:
$ 2.33万 - 项目类别:
TBI-induced adenosinergic dysregulation causes cognitive impairment and accelerates Alzheimer's disease pathology
TBI 诱导的腺苷能失调导致认知障碍并加速阿尔茨海默病病理
- 批准号:
10464395 - 财政年份:2022
- 资助金额:
$ 2.33万 - 项目类别:
Discovering Novel Genetic Causes and Molecular Mechanisms of Atypical Hemolytic Uremic Syndrome
发现非典型溶血性尿毒症综合征的新遗传原因和分子机制
- 批准号:
10293781 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Discovering Novel Genetic Causes and Molecular Mechanisms of Atypical Hemolytic Uremic Syndrome
发现非典型溶血性尿毒症综合征的新遗传原因和分子机制
- 批准号:
10677017 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Causes and consequences of declining B cell-mediated central T cell tolerance throughout the lifespan
B 细胞介导的中枢 T 细胞耐受性在整个生命周期中下降的原因和后果
- 批准号:
10393822 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Spinal cord injury causes liver pathology and metabolic dysfunction
脊髓损伤导致肝脏病理和代谢功能障碍
- 批准号:
10210615 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Spinal cord injury causes liver pathology and metabolic dysfunction
脊髓损伤导致肝脏病理和代谢功能障碍
- 批准号:
10377530 - 财政年份:2021
- 资助金额:
$ 2.33万 - 项目类别:
Increasing understanding of causes of stillbirth: Is the effect of maternal stress on stillbirth mediated by methylation of stress-related genes?
加深对死产原因的了解:母亲压力对死产的影响是否是由压力相关基因的甲基化介导的?
- 批准号:
10304121 - 财政年份:2020
- 资助金额:
$ 2.33万 - 项目类别:
Assessing the root causes of chronic inflammation in HIV-infected individuals using drugs of abuse
评估使用滥用药物的艾滋病毒感染者慢性炎症的根本原因
- 批准号:
9761514 - 财政年份:2017
- 资助金额:
$ 2.33万 - 项目类别:
Sleep Disturbance in Rheumatoid Arthritis: Phenotypes, Causes, and Impact
类风湿性关节炎的睡眠障碍:表型、原因和影响
- 批准号:
10237308 - 财政年份:2017
- 资助金额:
$ 2.33万 - 项目类别: